GFAP and myeloid sarcoma: Based on the application of PET/MRI with 18F-florbetapir in ADEM and MS, our results for the first time indicate this technique could quantitatively and non-invasively assess the myelin recovery in GFAP-A patients and helps to understand the pathological process of the disease.